Literature DB >> 34029695

Thioredoxin interacting protein regulates age-associated neuroinflammation.

Saifudeen Ismael1, Sanaz Nasoohi2, Lexiao Li3, Khurram S Aslam4, Mohammad Moshahid Khan5, Azza B El-Remessy6, Michael P McDonald7, Francesca-Fang Liao8, Tauheed Ishrat9.   

Abstract

Immune system hypersensitivity is believed to contribute to mental frailty in the elderly. Solid evidence indicates NOD-like receptor pyrin domain containing-3 (NLRP3)-inflammasome activation intimately connects aging-associated chronic inflammation (inflammaging) to senile cognitive decline. Thioredoxin interacting protein (TXNIP), an inducible protein involved in oxidative stress, is essential for NLRP3 inflammasome activity. This study aims to find whether TXNIP/NLRP3 inflammasome pathway is involved in senile dementia. According to our studies on sex-matched mice, TXNIP was significantly upregulated in aged animals, paralleled by the NLRP3-inflammasome over-activity leading to enhanced caspase-1 cleavage and IL-1β maturation, in both sexes. This was closely associated with depletion of the anti-aging and cognition enhancing protein klotho, in aged males. Txnip knockout reversed age-related NLRP3-hyperactivity and enhanced thioredoxin (TRX) levels. Further, TXNIP inhibition along with verapamil replicated TXNIP/NLRP3-inflammasome downregulation in aged animals, with FOXO-1 and mTOR upregulation. These alterations concurred with substantial improvements in both cognitive and sensorimotor abilities. Together, these findings substantiate the pivotal role of TXNIP to drive inflammaging in parallel with klotho depletion and functional decline, and delineate thioredoxin system as a potential target to decelerate senile dementia.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain aging; Functional decline; NLRP3-inflmmasome; Oxidative stress; TXNIP

Mesh:

Substances:

Year:  2021        PMID: 34029695      PMCID: PMC8277763          DOI: 10.1016/j.nbd.2021.105399

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   7.046


  61 in total

Review 1.  NLRP3 inflammasome activation in inflammaging.

Authors:  Eicke Latz; Peter Duewell
Journal:  Semin Immunol       Date:  2018-09-26       Impact factor: 11.130

2.  Regulation of oxidative stress by the anti-aging hormone klotho.

Authors:  Masaya Yamamoto; Jeremy D Clark; Johanne V Pastor; Prem Gurnani; Animesh Nandi; Hiroshi Kurosu; Masayoshi Miyoshi; Yasushi Ogawa; Diego H Castrillon; Kevin P Rosenblatt; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2005-09-26       Impact factor: 5.157

3.  Gait speed and survival in older adults.

Authors:  Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

4.  Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice.

Authors:  Tauheed Ishrat; Islam N Mohamed; Bindu Pillai; Sahar Soliman; Abdelrahman Y Fouda; Adviye Ergul; Azza B El-Remessy; Susan C Fagan
Journal:  Mol Neurobiol       Date:  2014-06-18       Impact factor: 5.590

5.  The neuroprotective effect of Klotho is mediated via regulation of members of the redox system.

Authors:  Ella Zeldich; Ci-Di Chen; Teresa A Colvin; Erin A Bove-Fenderson; Jennifer Liang; Tracey B Tucker Zhou; David A Harris; Carmela R Abraham
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

Review 6.  Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.

Authors:  Sanaz Nasoohi; Saifudeen Ismael; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

7.  Preventing β-cell loss and diabetes with calcium channel blockers.

Authors:  Guanlan Xu; Junqin Chen; Gu Jing; Anath Shalev
Journal:  Diabetes       Date:  2012-04       Impact factor: 9.461

Review 8.  Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.

Authors:  Eiji Yoshihara; So Masaki; Yoshiyuki Matsuo; Zhe Chen; Hai Tian; Junji Yodoi
Journal:  Front Immunol       Date:  2014-01-09       Impact factor: 7.561

9.  TXNIP shuttling: missing link between oxidative stress and inflammasome activation.

Authors:  Troy Lane; Brenda Flam; Richard Lockey; Narasaiah Kolliputi
Journal:  Front Physiol       Date:  2013-03-21       Impact factor: 4.566

10.  Regional hippocampal differences in AKT survival signaling across the lifespan: implications for CA1 vulnerability with aging.

Authors:  T C Jackson; A Rani; A Kumar; T C Foster
Journal:  Cell Death Differ       Date:  2008-11-28       Impact factor: 15.828

View more
  4 in total

1.  TXNIP inhibits the progression of osteosarcoma through DDIT4-mediated mTORC1 suppression.

Authors:  Yuhao Yuan; Qing Liu; Ziyi Wu; Wei Zhong; Zili Lin; Wei Luo
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

2.  Verapamil, a possible repurposed therapeutic candidate for stroke under hyperglycemia.

Authors:  Saifudeen Ismael; Tauheed Ishrat
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

Review 3.  α-Arrestins and Their Functions: From Yeast to Human Health.

Authors:  Kacper Zbieralski; Donata Wawrzycka
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

Review 4.  Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response.

Authors:  Islam N Mohamed; Luling Li; Saifudeen Ismael; Tauheed Ishrat; Azza B El-Remessy
Journal:  World J Diabetes       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.